产品名称
PLGA微球, 50 μm average diameter
form
powder
average diameter
50 μm
density
1.3 g/cm3
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
Plain PLGA particles for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.
General description
Degradex® is made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a Mw of 30,000.
To re-constitute:
To re-constitute:
- Remove the product from freezer.
- Wait until temperature rises to the ambient temperature.
- Add DI water or buffer to the container.
- Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.
Legal Information
Degradex is a registered trademark of Phosphorex, Inc.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
商品
Biomaterials science integrates smart materials into biological research, requiring a deep understanding of biological systems.
Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.
Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持